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Background: Although pyogenic liver abscess (PPLA) fatalities are decreasing owing to early diagnosis and
effective treatments, PPLA-associated complications still exist. The purpose of this study was to analyze the
characteristic features of initial presentations and final outcomes of PPLA caused by different pathogens.
Methods: This retrospective study collected and analyzed information regarding initial presentations and final
outcomes in patients diagnosed with PPLA at admitted at Changhua Christian Hospital from January 1 to
December 31, 2010.
Results: During the study period, we analyzed the records of a total of 134 patients with documented PPLA. There
were no significant causative pathogen-related differences in symptoms at initial presentation. Compared with the
survivor group, patients in the mortality group were characterized by male gender (p < 0.001), malignancy (p < 0.001),
respiratory distress (p =0.007), low blood pressure (p = 0.024), jaundice (p = < 0.001), rupture of liver abscess (p < 0.001),
endophthalmitis (p = 0.003), and multiple organ failure (p < 0.001). No patients received liver transplantation or were
diagnosed with HIV during the study period. According to univariate logistic regression analysis, gender (OR = 1.185, 95%
CI: 0.284–11.130, p = 0.006), malignancy (OR = 2.067, 95% CI: 1.174–13.130, p = 0.004), respiratory distress (OR = 1.667, 95%
CI: 1.164–14.210, p = 0.006), low blood pressure (OR = 2.167, 95% CI: 2.104–13.150, p = 0.003), jaundice (OR = 1.9, 95% CI:
1.246–3.297, p = 0.008), rupture of liver abscess (OR = 5.167, 95% CI: 2.194–23.150, p = 0.003), endophthalmitis (OR = 2.167,
95% CI: 1.234–13.140, p = 0.005), and multiple organ failure (OR = 3.067, 95% CI: 1.184–15.150, p = 0.001) differed
significantly between the mortality and survivor groups.
Conclusion: Although the initial presentations of PPLA caused by different pathogens were similar, there were significant
differences in mortality in cases involving: (1) male patients, (2) malignancy, (3) initial respiratory distress, (4) initial low
blood pressure, (5) jaundice, (6) rupture of liver abscess, (7) endophthalmitis, , and (8) multiple organ failure. We strongly
recommend using a severity score of the disease to determine the risk of mortality for each patient with PPLA. In order to
prevent complications and reduce mortality, more attention must be paid to high-risk PPLA patients.
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Primary pyogenic liver abscess (PPLA) is not a rare disease
in Taiwan [1]. With the introduction of percutaneous drain-
age, surgical drainage, and effective antibiotics, the treat-
ment of PPLA has improved over the last 10 years [2].
However, PPLA still causes significant morbidity and* Correspondence: changhua@cch.org.tw
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unless otherwise stated.mortality and if not diagnosed and treated early, is almost
always fatal [3].
The clinical presentation of liver abscess in Taiwan has
changed over the years owing to antibiotic overuse and as-
sociated drug resistance, higher prevalence of chronic or
malignant diseases, and population ageing [4]. Despite the
increased understanding of this new invasive syndrome
[4], only earlier diagnosis and effective treatment can
minimize the occurrence of sequelae and improve clinical
outcomes. However, the literature describing initial clinical
presentations of PPLA and early ultrasonography findings
is sparse [5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Chen et al. BMC Gastroenterology 2014, 14:133 Page 2 of 7
http://www.biomedcentral.com/1471-230X/14/133Since the clinical symptoms of PPLA are variable, and
some of the PPLA causative pathogens, such as Klebsiella
pneumoniae (K. pneumoniae), are highly resistant to the
most effective antibiotic therapies, it is very important to
develop accurate and effective diagnosis and treatment ap-
proaches for PPLA. Early diagnosis of patients with liver
abscess is one of the most challenging tasks for a phys-
ician. Over the past 3 decades, ultrasound has had an im-
portant role in the diagnosis of this disease. Even with
aggressive treatment with antibiotics and drainage, how-
ever, the mortality rate of liver abscess remains high [6-8].
It is often difficult to promptly diagnose the initial
stage of PPLA because ultrasound findings are typically
negative or non-specific and subclinical symptoms and
signs are absent. We performed a cross-sectional study
of all of the confirmed cases of PPLA in central Taiwan
in order to (1) elucidate the risk factors for PPLA, (2)
compare the most common ultrasound findings between
PPLA cases caused by different pathogens, and (3) iden-
tify the prognostic factors for mortality.
Methods
Setting and population
The population of Changhua is mostly served by the
Changhua Christian Hospital System (CCHS), which has
maintained comprehensive clinical records since 1867.
Changhua County is located in central Taiwan, and it had
a population of 140,277 in 2000. Changhua Christian Hos-
pital (CCH), a 1,800-beds tertiary referral medical center
located in northern Changhua County, is a component of
CCHS. CCH has been a Joint Commission International-
accredited hospital since 2009. This cross-sectional retro-
spective study of PPLA was conducted by reviewing the
computerized medical records collected at CCH from
January 1 to December 31, 2010. The study was approved
by the institutional review board of Changhua Christian
Hospital (CCH IRB No. 131116).
Case findings and analysis
Cases of PPLA at CCH were identified using the
microbiological databases and medical records in the
International Classification of Diseases, Ninth revision,
Clinical Modifications (ICD-9-CM). We used ICD-9-CM
code number 572.0 to find the cases. Each case had a med-
ical chart that contained medical diagnoses, surgical inter-
ventions, and other key data from the medical records.
The medical records of all the PPLA cases were manually
reviewed by the primary investigator (C.C.H.) to confirm
the diagnosis (using CCHS resources). Cases that were
judged ambiguous were reviewed by the secondary investi-
gator (S.S.W.). For example, although in some patients the
abscess culture revealed Corynebacterium urealyticum,
blood cultures grew Staphylococcus epidermidis, possibly
because of skin contamination. Discrepancies between theabscess and blood cultures were also observed in some
cases with secondary pyogenic liver abscess, such as after
foreign body penetration of the alimentary tract. Only the
first episode of PPLA in each person during the study
period was included in statistical analyses.
PPLA was diagnosed based on clinical presentation,
imaging findings of ultrasonography, abdominal com-
puted tomography (CT) scans, and microbiological re-
sults. The treatment protocol for PPLA is described in
the Additional file 1. The choice of the antimicrobial
agent for the treatment was based on the results of the
antibiotic susceptibility test. The following patient details
were recorded: age, sex, date of admission, severity of
underlying disease, comorbidity, diagnosis, clinical signs
and symptoms, microbiological results, response to ther-
apy, complications, and outcome. Only primary cases
were collected, whereas those cases with distant metas-
tasis from significant pyogenic infectious sources other
than the liver were excluded. The severity of underlying
disease was categorized according to the McCabe &
Jackson criteria [9]. Microbiological data were collected
only at the initial stage before the antibiotic therapy. All
bacterial pathogens were collected, including anaerobes.
If both blood and pus cultures were positive, we ana-
lyzed only the pus culture taken directly from the liver
abscess. If there were recurrent PPLA episodes, only the
first instance was taken into account.
Microbiological data were collected by reviewing the
computerized records of the Microbiological Laboratory of
CCH dated from January 1 to December 31, 2010. Blood
culture analysis was performed for every case with sus-
pected sepsis. We used a BACTEC NR-860 system (Becton
Dickinson Diagnostic Instrument Systems, Cockeysville,
MD, USA) to detect pathogens, Gram staining to deter-
mine morphology, and the API-20 series kit (bioMerieux
Vitek, Hazelwood, MO) for biochemical reactions. Anti-
biotic susceptibilities were determined using the disk
diffusion method (BBL™ Sensi-Disc™, Becton Dickinson) ac-
cording to the guidelines of the Clinical and Laboratory
Standards Institute [10].
Definitions
PPLA was defined as the final diagnosis of primary pyo-
genic liver abscess in an adult patient (age ≥18 years)
confirmed with clinical presentation, imaging findings,
microbiological results, and/or pathological findings. Pa-
tients with the following characteristics were excluded: (1)
age <18 years; (2) unavailable blood and pus culture data;
(3) incomplete data; (4) inconsistencies among ICD-9-CM
data, microbiological data, and medical records; (5)
amebic liver abscess; and (6) secondary pyogenic liver ab-
scess, such as pyogenic liver abscess secondary to foreign
body penetration of the alimentary tract. Initial presenta-
tion was defined as the symptoms, signs, laboratory data
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served within 48 h of admission. Patient delay was defined
as the time interval between the onset of symptoms and
presentation to the hospital. Delay of antibiotic therapy
was defined as the time interval between the presentation
to the hospital and the start of antibiotic therapy. Pro-
longed delay was defined as a delay greater than the me-
dian. We defined final outcome as either a status with
complications or patient’s death. PPLA complications were
rupture of liver abscess, endophthalmitis, and multiple
(more than 3) organ failures attributable to PPLA. The
K. pneumoniae group included patients whose microbio-
logical culture revealed K. pneumoniae. The non-Klebsiella
Gram-negative bacilli (GNB) group comprised patients
whose microbiological culture revealed GNB other than
K. pneumoniae, including Escherichia coli, K. terrigena,
Morganella morganii, Pseudomonas aeruginosa, and Pro-
teus mirabilis. The aerobic Gram-positive cocci (GPC)
group included patients whose microbiological culture re-
vealed GPC, including Staphylococcus aureus and viridans
streptococci. The anaerobes group was composed of pa-
tients with anaerobic organisms in the microbiological cul-
ture, including Fusobacterium necrogenes, F. varium, and F.
nucleatum. The mixed infection group included patients
with more than 1 pathogen in the microbiological culture.
Patients with polymicrobial infections were assigned to the
mixed infection group. The mortality group included indi-
viduals who died within 6 weeks during the hospitalization
from PPLA-related causes. The survivor group included
those who did not die during the hospitalization. Abscesses
were considered cryptogenic in origin when no causative le-
sions were apparent.
To analyze case characteristics and laboratory parame-
ters of each group, descriptive statistics were calculated
using SPSS version 10.0 for Windows (SPSS Inc., Chicago,
IL, USA). Chi-square and Fisher’s exact tests were used for
analysis. Results were considered significant if the p-value
was <0.05.
Results
One hundred fifty PPLA cases were diagnosed from
January 1 to December 31, 2010. Sixteen cases were ex-
cluded because of inadequate data, leaving a total of 134
patients with documented PPLA. The incidence of PPLA
in adults served by CCH was 275.4/100,000 patient-
years in 2010. The male to female ratio was 0.3 (29.1).
The mean age was 59.4 years (mean ± SD: 59.4 ± 16.3; me-
dian: 62.9; range: 9–88). The mean length of hospitalization
was 14.6 days (mean ± SD: 14.2 ± 7.3; median: 15; range: 1–
58). Clinically, 118 of 134 (88.1%) patients had fever, and 38
(26.7%) had low blood pressure (<90/60 mmHg) upon ad-
mission for PPLA. One hundred nine (85.2%) patients had
right upper quarter pain at admission. The abscesses were
located at the right liver lobe in 92 (68.7%), left lobe in 21,and both lobes in 7 cases. The liver abscess size ranged
from 1 to more than 5 cm in diameter. One hundred
twenty-seven (94.8%) patients had a single abscess, and 7
had multiple abscesses. Ninety-five (70.9%) out of 134 pa-
tients had abscesses that resulted from infection with
K. pneumoniae. There were no statistically significant dif-
ferences in the initial clinical presentations among the 134
patients, and symptoms at initial clinical presentations in-
cluded fever, chills, abdominal pain, anorexia, malaise,
nausea, emesis, body temperature higher than 38.3°C,
right upper quadrant tenderness, Murphy's sign, hepato-
megaly, disturbance of consciousness, and ascites. The ini-
tial ultrasonographic findings and the results of the initial
ultrasound-guided aspiration biopsy are listed in Table 1.
Every patient received treatment according to the
PPLA treatment protocol (see Additional file 1). In every
case, an empirical antibiotic treatment was started at the
onset of the clinical signs of infection. Antibiotic therap-
ies were changed based on the results of antibiotic sus-
ceptibility tests. Twenty-one (15.7%) patients developed
complications, including endophthalmitis, PPLA rup-
ture, and multiple organ failure. Of 134 patients, 6 died,
leading to a crude mortality rate of 4.5% (6/134). The
risk factors for mortality associated with PPLA included
extra-hepatic complications, PPLA rupture, and multiple
organ failure. One of 6 patients did not receive drainage
because of bleeding tendency and ascites.
We compared the survivor and mortality groups to
analyze the risk factors of the final outcome among the 134
patients with PPLA (Table 2). When compared with
the survivor group, patients with mortality were male
(26.6% vs. 83.3%, p < 0.001), malignancy (28.9% vs. 66. 7%,
p < 0.001), respiratory distress (11.7% vs. 50%, p= 0.007),
low blood pressure (29.7% vs. 33.3%, p= 0.001), jaundice
(15.6% vs. 83.3%, p < 0.001), rupture of liver abscess (0% vs.
33.3%, p < 0.001), endophthalmitis (5.6% vs. 33.3%, p=
0.003), and multiple organ failure (3.1% vs. 100%, p < 0.001).
In our study, no patients received liver transplantation, and
none were diagnosed with HIV during the study period.
According to the results of univariate logistic regression
analysis, gender (OR= 1.185, 95% CI: 0.284–11.130, p =
0.006), malignancy (OR = 2.067, 95% CI: 1.174–13.130, p=
0.004), respiratory distress (OR= 1.667, 95% CI: 1.164–
14.210, p= 0.006), low blood pressure (OR= 2.167, 95% CI:
2.104–13.150, p= 0.003), jaundice (OR= 1.9, 95% CI: 1.246–
3.297, p = 0.008), rupture of liver abscess (OR= 5.167, 95%
CI: 2.194–23.150, p= 0.003), endophthalmitis (OR= 2.167,
95% CI: 1.234–13.140, p= 0.005), and multiple organ failure
(OR= 3.067, 95% CI: 1.184–15.150, p= 0.001) differed sig-
nificantly between the mortality and survivor groups.
Discussion
To the best of our knowledge, this is the first study to
analyze the initial clinical presentations and initial














Negative or equivocal findings of
ultrasonographic examinations at
first examination
8 1 1 0 1 11 1.000
Difficulty at initial aspiration 8 1 0 0 0 9 0.284
Gas formation 21 6 0 0 1 28 0.591
Multiple abscesses 2 4 1 0 0 7 0.022
Complications 5 3 1 0 1 10 0.001
Mortality 6 3 1 0 0 11 0.297
Notes: abbreviation: GNB Gram negative bacilli, GPC Gram positive cocci.
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by different pathogens. Importantly, in 6 (7.5%) of 80 pa-
tients with bacteremia, infectious foci at the initial stage
were not detected during the abdominal ultrasonographic
examination (Table 1), but were revealed with abdominal
CT. Lin, et al. showed that 38 (14.1%) of 268 PPLA pa-
tients had false-negative findings on ultrasonography at
initial presentation [5]. Appropriate targeted antimicrobial
treatments, combined with drainage of liver abscesses,
have already increased PPLA survival rates [1,4]. Earlier
diagnosis of PPLA could minimize sequelae and improve
clinical outcomes [4]. Therefore, clinicians should pay spe-
cial attention to bacteremic patients without obvious in-
fectious foci. In particular, abdominal CT may be useful in
patients at high risk of PPLA if initial results of abdominal
ultrasonography are negative.
Although 9 of the 134 (6.7%) patients from this study
did not undergo ultrasound-guided aspiration biopsy be-
cause of aspiration difficulties, their final clinical outcomes
did not differ from those of the rest of the patients
(Table 2). Evaluation of the final outcomes and duration of
the treatment with antimicrobial agents revealed no sig-
nificant differences between the patients without gas-
forming and multiple abscesses (Table 1). In contrast to
the results of Chou et al. [11], the current study and some
previous studies [12,13] suggest that abscess multilocula-
tion is not the single risk factor for PPLA mortality.
We compared the clinical presentations among different
causative pathogens, including K. pneumonia, the main
cause of liver abscesses in Taiwan with increasing infection
prevalence [14]. There were no significant differences
among the causative pathogens. In agreement with the
previous reports from Taiwan, K. pneumoniae was the
most predominant pathogen [15]. Sachdev et al. suggested
that serotype K1 is an important factor of complicated en-
dophthalmitis in K. pneumonia-caused PPLA [16]. We did
not test the serotype of K. pneumoniae because of the lack
of adequate equipment. In brief, there was no significant
difference in K. pneumonia-related PPLA (97.9% vs. 2.1%,
p = 0.297) between the survival and mortality groups in
this study. The different of our results from previousstudies [4,14,15] could be related to multiple factors, in-
cluding initial broad-spectrum antibiotics prescription,
and fewer K1 serotype of K. pneumoniae in Changhua
County, and it’s needed further experiments to elucidate
these points.
With the development of appropriate antimicrobial
treatments and drainage methods for liver abscesses,
PPLA survival rates have increased during this century
[1,4]. In our study population, the crude mortality rate
was 4.5% (6/134). Overall, the crude PPLA mortality rate
has varied in the recent decade, with the average value be-
ing around 5% [7,16-18]. The mortality rates varied ac-
cording to the differences in the geographic origins, study
designs, study arms, and patient populations [4,17]. A lit-
erature review indicated that malignancy on presentation
is an important risk factor for PPLA mortality [18-20],
similar to our results. In our study, the risk factors associ-
ated with PPLA mortality included gender, jaundice, rup-
ture of liver abscess, and multiple organ failure. Some of
these factors have been described previously, including
jaundice [21], rupture of liver abscess [21,22], and endoph-
thalmitis [22]. Although the differences between genders
could be related to testosterone levels [23], further experi-
ments will be need to verify this. Multiple organ failure,
initial low blood pressure, and initial respiratory distress
are poor prognostic factors that result from higher disease
severity, contributing to the higher mortality rates in the
corresponding groups. In agreement with the results of
Lin et al. [24], our study revealed an association between
the prolonged delay of effective antibiotics and aspiration/
drainage therapies and the risk of mortality. Although in
the present study the time intervals between the presen-
tation and initiation of effective antibiotics therapy
varied within a wide range because of the non-specific
and highly variable nature of PPLA presentations, we
strongly recommend that an early, empirical, short-
course, broad-spectrum antibiotics therapy is consid-
ered when persistent fever or unstable hemodynamics
occur during the initial stages of the empirical therapy.
The Lin’s report identified 6 independent risk factors
predicting severe complications of K. pneumonia-related
Table 2 Analysis of demographic data, clinical features, concomitant diseases and outcome among 134 patients with
primary pyogenic liver abscess
Survivor Mortality Total Univariate logistic
regression analysis




Gender, male (%) 34 (26.6%) 5 (83.3%) 39 (29.1%) <0.001 1.879 2.284–11.130 0.006
Age, mean ± SD*1 (years) 53.6 ± 18.9 67.5 ± 7.4 59.4 ± 16.3 0.705
Length of hospitalization, mean ± SD (days) 10.2 ± 8.3 17.2 ± 6.3 14.2 ± 7.3 0.612
Underlying diseases & co-morbidity
Category C of disease severity
on admission a*2, mean ± SD
15 (11.7%) 2 (33.3%) 17 (10.4%) 0.025
Coexisting diseases, no. (%)
Diabetes mellitus 84 (65.6%) 2 (33.3%) 86 (64.2%) 0.055
Biliary disorders*3 44 (34.4%) 4 (66. 7%) 48 (35.8%) 0.055
Alcoholism 45 (35.2%) 2 (33.3%) 47 (35.1%) 1.000
Liver cirrhosis 46 (35.9%) 3 (50%) 49 (36.6%) 0.530
Malignancy*4 37 (28.9%) 4 (66. 7%) 41 (30.6%) <0.001 2.067 1.174–13.130 0.004
Uremia 49 (38.3%) 3 (50%) 52 (37.6%) 0.750
Delay issue
Patient delay (days), mean (range) 10 (1–124) 9 (1–91) 0.569
Total delay (days), mean (range) 19 (1–124) 17 (1–91) 0.459
Symptoms and signs on admission, no. (%)
Fever/chills 118 (92.2%) 4 (66.7%) 122 (91.0%) 0.069
Abdominal pain 117 (91.4%) 5 (83.3%) 122 (91.0%) 0.256
Anorexia 12 (9.4%) 2 (33.3%) 14 (10.5%) 0.056
Malaise 115 (89.9%) 5 (83.3%) 120 (89.6%) 0.322
Nausea/emesis 114 (89.1%) 4 (66.7%) 118 (12.7%) 0.057
Respiratory distress*5 15 (11.7%) 3 (50%) 18 (13.4%) 0.007 1.667 1.164–14.210 0.006
Signs on admission, no. (%)
Body temperature > 38.3°C 111 (86.7%) 6 (100%) 117 (87.3%) 0.358
Blood pressure < 90/60 mmHg 38 (29.7%) 2 (33.3%) 40 (29.8%) 0.001 2.167 2.104–13.150 0.003
Right upper quadrant tenderness 109 (85.2%) 3 (50%) 112 (83.6%) 0.701
Jaundice 20 (15.6%) 5 (83.3%) 25 (18.7%) <0.001 1.900 1.246–3.297 0.008
Murphy's sign*6 21 (16.4%) 1 (16.7%) 22 (16.4%) 0.869
Hepatomegaly 22 (17.2%) 0 (0%) 22 (16.4%) 0.125
Disturbance of consciousness 23 (17.8%) 1 (16.7%) 24 (17.9%) 0.980
Ascites 24 (18.8%) 1 (16.7%) 25 (18.7%) 1.000
Source of infection, no. (%)
Biliary origin*7 32 (25%) 4 (66.7%) 36 (26.9%) 0.069
Cryptogenic origin 33 (25.8%) 1 (16.7%) 34 (25.4%) 0.729
Sonographic findings at first examination, no (%)
Negative findings and equivocal 5 (83.3%) 1 (16.7%) 6 (4.5%) 0.077
Single abscesss (77%) 101 (98.1%) 2 (1.9%) 103 (77%) 0.063
Right lobe (72.3%) 95 (97.9%) 2 (2.1%) 97 (72.3%) 0.071
Multiple abscesses (23%) 30 (96.8%) 1 (3.2%) 31(23%) 1.000
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Table 2 Analysis of demographic data, clinical features, concomitant diseases and outcome among 134 patients with
primary pyogenic liver abscess (Continued)
Gas formation 27 (96.4%) 1 (3.6%) 28 (20.9%) 1.000
Difficulty at initial aspiration 8 (88.9%) 1 (11.1%) 9 (6.7%) 0.161
Microbiology 0.028
Klebsiella pneumonia 93 (97.9%) 2 (2.1%) 95 (70.8%)
Non- Klebsiella GNB 28 (90.3%) 3 (9.7% ) 31 (23.1%)
Aerobic GPC 4 (80%) 1 (20%) 5 (3.7%)
Anaerobes 1 (100%) 0 1 (0.4%)
Mixed infection 2 (100%) 0 2 (1.4%)
Treatment
Doctor delay of effective antibiotics
therapy (days), mean (range)
8 (0–33) 4 (0–37) 0.101
Prolonged doctor delay of effective
antibiotics therapy (>8 days)
78 (61.5%) 2 (33.3%) 0.118
Delay of aspiration/drainage (days), mean (range) 9 (0–33) 7 (0–27) 0.201
Prolonged delay of aspiration/drainage
therapy (>9 days)
78 (61.5%) 1 (16.7%) 0.008
Complications, no. (%)
Rupture of liver abscess 0 (0%) 2 (33.3%) 2 (1.5%) <0.001 5.167 2.194–23.150 0.003
Endophthalmitis, related to PPLA 7 (5.6%) 2 (33.3%) 9 (6.7%) 0.003 2.167 1.234–13.140 0.005
Multiple organ failure, related to PPLA 4 (3.1%) 6 (100%) 10 (7.5%) <0.001 3.067 1.184–15.150 0.001
P-value by Chi-square test or Fisher's exact test when appropriated.
Abbreviation: GNB Gram negative bacilli, GPC Gram positive cocci.
Notes:*1SD standard deviation, *2Disease severity was categorized according to McCabe & Jackson criteria, and Category C meant the rapid fatal group; *3Biliary
disorders including biliary stone diseases (cholelithiasis, choledocholithiasis, or hepatolithiasis) and prior hepatobiliary; surgery; *4Malignancy including lung cancer,
pancreatic cancer, breast cancer, esophagus cancer, stomach cancer, colon cancer, lymphoma, prostate cancer, hematological malignancy, oral cancer, solid tumor
and large intestines. Non-digestive system cancer; *5Respiratory distress including shortness of breath, dyspnea, chest distress, hypoxemia (saturation of oxygen is
less than 95%); *6Murphy’s sign: deep inspiration or cough during subcostal palpation of RUQ producing increased pain and inspiratory arrest; *7Biliary origin of
liver abscess including suppurative cholangitis and acute cholecystitis.
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phosphatase > 300 U/L, gas formation in the abscess,
APACHE III score > 40, use of cefazolin (instead of
extended-spectrum cephalosporin), and delayed drain-
age [24,25].
Our study has several strengths. Most importantly, it
represents an reliable reference for evaluating the initial
clinical features of PPLA, providing valuable epidemio-
logical information regarding the confirmed PPLA cases
in central Taiwan. In addition, the prognostic factors,
including the initial presentations, were analyzed. The
limitations of this study include the retrospective cross-
sectional design. The true prevalence of PPLA may be
under-estimated because we collected only the cases with
definitive diagnosis and positive microbiological findings
in order to reduce potential confounding factors. Every
case of polymicrobial liver abscess was considered a single
case, with the predominant pathogen determined based
on the results of microbiological evaluation. Similarly, only
the results of liver abscess pus culture were taken into ac-
count if both blood and pus cultures were positive. Fur-
thermore, since recurrent PPLA was counted as one case,the true incidence of PPLA is likely to be under-estimated.
Finally, we did not calculate the time interval between de-
finitive diagnosis and the initiation of effective antibiotic
treatment.
Conclusions
Because of early diagnosis and availability of more effective
treatments, PPLA mortality is currently decreasing. Never-
theless, complications and mortality were still present in
the current study. Although the initial presentations of
PPLA were not significantly different among the groups
with different causative pathogens, the disease was treated
successfully in the majority of the patients. The mortality of
the patients with PPLA was associated with: (1) male gen-
der, (2) presence of malignancy, (3) initial respiratory dis-
tress, (4) initial low blood pressure, (5) jaundice, (6) rupture
of liver abscess, (7) endophthalmitis, and (8) multiple organ
failure. We strongly recommend using a disease severity
score to determine the risk of mortality for each patient
with PPLA. In order to prevent complications and reduce
mortality, more attention must be paid to high-risk PPLA
patients.
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